Project Grant R01MH135079
Award Date
8/26/24
Completion Date
5/31/29
Dollars Obligated
$2.8M
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
This Project Grant award of $919,453, awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to identify the immunobiological mechanisms underlying the development of depression during the perimenopause transition in women. The primary objectives are to: 1) determine plasma tryptophan metabolite and cytokine patterns in perimenopausal depression, 2) define epigenetic mechanisms in lymphocytes that confer vulnerability to...
This Project Grant award, totaling $576,926 and awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to characterize the cellular and molecular changes in the human anterior hippocampus (a brain region critical for emotion regulation) across the menopausal transition. The research will utilize single-nucleus multiome analysis and micro-C analysis to define the shifts in gene expression, chromatin states, and 3D genome...
The National Institute of Mental Health (NIMH) awarded a $381,915 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Icahn School of Medicine at Mount Sinai. The 2-year grant (7/23/2024 - 6/30/2026) will fund research to determine the neural and physiological biomarkers of mood-like states in non-human primates. The project will combine computational models of affect with simultaneous neurophysiology recordings across multiple brain regions to investigate how prediction error...
This Project Grant award from the National Institute of Mental Health (NIMH), under CFDA Program 93.242 Mental Health Research Grants, will support a multi-site study to examine the role of neuroactive steroids and GABA-A receptor plasticity in premenstrual dysphoric disorder (PMDD) and its treatment with low-dose selective serotonin reuptake inhibitors. The $1,531,300 award will fund research over a 5-year period starting August 1, 2024 at the University of Virginia. The study aims to elucidate...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $100,748.00 to the Icahn School of Medicine at Mount Sinai to investigate the neurocomputational mechanisms underlying the influence of social interaction on mood. The key objectives of this 2.5-year research project are to: 1) use computational modeling to examine how norm prediction errors influence short-term and long-term changes in...
The federal Project Grant award K23MH136325 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will provide $196,776 to the Emma Pendleton Bradley Hospital, doing business as Bradley Hospital, to conduct research on the effects of ovarian steroids on mood and sleep in adolescent females. The study will characterize hormone sensitivity in 50 female adolescents aged 11-14 years by collecting daily assessments of mood, sleep, and...
This Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $486,416 to The Johns Hopkins University to conduct research on the pathophysiology and treatment mechanisms of premenstrual dysphoric disorder (PMDD). The key objectives are to examine fluctuations in GABAergic neuroactive steroids, GABA-A receptor subunit expression, and GABAergic neurosteroidogenic enzyme expression in women with PMDD, both at baseline and in response...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) program, will provide $1,558,726 over a 5-year period from January 1, 2025 to December 31, 2029 to the University of Pittsburgh. The funding will support a longitudinal investigation of the neurobiological changes in brain structure, function, and cognition that occur during the perimenopause stage of the menopause transition in women. The study aims to elucidate the relationship between...
This federal Project Grant award of $135,989 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research to comprehensively map the influence of gonadal hormones on network-level coding of proactive social behavior and related variables, and identify sites of in vivo hormonal action. The research aims to unravel the neuroendocrine mechanisms that promote proactive social behavior, a critical step toward understanding the...
This Project Grant award of $1,541,456 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a study on the neural mechanisms underlying the effects of menstrual cycle hormones on attention-deficit/hyperactivity disorder (ADHD) symptoms and cognition in young adult females with ADHD. The primary goals are to elucidate how menstrual cycle phase and hormonal changes impact the neural circuitry involved in response inhibition...